GENUINE PARTS CO
No SEC Form 4 filings for $GPC in the last 30 days.
See all $GPC insider activity →Genuine Parts (GPC) has a mean price target of $141, a 3.5% premium over its current market price, with the highest target at $170, suggesting a 24.8% upside. Analysts' predictions vary on the stock's future performance.
Genuine Parts (GPC) reported that EVP and Chief People Officer Jennifer Hulett disposed of 302 shares at $134.54 each to cover exercise price or tax liability, leaving her with 21,311 shares. Her holdings increased by 66 shares due to dividend accrual.
Genuine Parts (GPC) shares rose 11.8% since its last earnings report, beating Q2 estimates with $2.15 EPS and $6.54B revenue. Growth was driven by Industrial sales and broad demand, though margins were mixed in Automotive.
Over the past 7 days, alphai's AI scored 1 news story mentioning GPC (GENUINE PARTS CO). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent GPC coverage spans financial news, earnings and corporate actions.
Potential price appreciation if targets are acted upon.
Small insider exercise; unlikely to move price.
Strong earnings and revenue beat suggest near‑term upside momentum.
The article signals a large, disclosed accumulation by a value-focused investor, but it is not a company fundamental update.
The separation plan is a structural change that can re-rate the market’s view of segment value, capital allocation, and execution risk.
alphai scores every news story that mentions GPC with an AI model for sentiment and relevance, and aggregates insider trades from GENUINE PARTS CO's SEC EDGAR Form 4 filings. Figures refresh continuously.
Genuine Parts (GPC) has a mean price target of $141, a 3.5% premium over its current market price, with the highest target at $170, suggesting a 24.8% upside. Analysts' predictions vary on the stock's future performance.
1 min readGenuine Parts (GPC) reported that EVP and Chief People Officer Jennifer Hulett disposed of 302 shares at $134.54 each to cover exercise price or tax liability, leaving her with 21,311 shares. Her holdings increased by 66 shares due to dividend accrual.
1 min readGenuine Parts (GPC) shares rose 11.8% since its last earnings report, beating Q2 estimates with $2.15 EPS and $6.54B revenue. Growth was driven by Industrial sales and broad demand, though margins were mixed in Automotive.
2 min readAccording to Baupost Group’s latest portfolio disclosure, Seth Klarman’s firm increased its Genuine Parts Company (GPC) stake by 89% in Q2 to 2.82 million shares worth about $332.3 million. Genuine Parts plans to separate Global Automotive and Global Industrial. Industrial Q2 sales rose ~7% and EBITDA rose ~10% to $316 million.
5 min readGenuine Parts (GPC) said it plans to split its auto and industrial parts units into two separate public companies, with completion expected in Q1 2027. The company cited a strategic review to improve focus, execution, and investment flexibility. It reported Q4 EPS of $1.55 on $6.0B revenue versus Wall Street expectations of $1.81 on $6.07B.
4 min readSimply Wall St says Genuine Parts (GPC) declared a regular quarterly dividend of $1.0625 per share, payable Oct. 2, 2026 to holders of record Sept. 4, 2026. The article links investor reaction to a “golden cross” and upgraded earnings estimates, citing expected annualized cost savings of over $200 million by 2026 and projections of $28.3B revenue and $1.4B earnings by 2029.
4 min readDigital Commerce 360 reports MSC Industrial Supply’s fiscal Q3 2026 e-commerce revenue exceeded $1 billion. The article also cites Fastenal’s Q2 2026 digital sales growth, Omnia Partners adding suppliers to its Opus platform, and Deloitte research urging B2B suppliers to structure product data for AI agents. It notes planned splits/spin-offs at Genuine Parts and Resideo/ADI.
5 min readThe article describes preclinical findings on GPC-100 (burixafor), a CXCR4 antagonist, as a potential preconditioning agent for in vivo CAR-T. According to investigators, GPC-100 increased circulating CD4 and CD8 T cells, and adding propranolol (B2AR inhibitor) boosted CD8 mobilization about 7-fold, with CD8 share rising from 21% to 34%.
5 min readThe article highlights three Dividend Kings for long-term income: Johnson & Johnson (JNJ), Kimberly-Clark (KMB), and Genuine Parts Company (GPC). It cites JNJ Q1 2026 revenue of $24.06B and raised FY2026 guidance, plus a 3.1% dividend increase. KMB reports Q1 2026 revenue $4.16B and EPS $1.97, with a 4.7% trailing yield. GPC reports Q1 2026 revenue $6.26B and EPS $1.77, with 70 years of dividend increases and a planned separation in Q1 2027.
7 min readGenuine Parts Company (GPC) reported Q1 2026 net sales of about $6.0B, up from about $5.8B in Q1 2025. Adjusted EPS rose to about $2.20 from about $2.10. Adjusted operating margin improved to about 8.5% from about 8.3%. The company also cited Q1 operating cash flow near $500M and a fiscal 2025 dividend around $3.80 per share.
5 min read
